Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-25T05:49:55.446Z Has data issue: false hasContentIssue false
  • English
  • Français

Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing

Published online by Cambridge University Press:  13 July 2011

Alessandro Sona ,
Ping Zhang ,
David Ames ,
Ashley I. Bush ,
Nicola T. Lautenschlager ,
Ralph N. Martins ,
Colin L. Masters ,
Christopher C. Rowe ,
Cassandra Szoeke  and
Kevin Taddei
...Show all authors
Alessandro Sona
Affiliation:
AOU San Giovanni Battista - Molinette, Geriatria e Malattie Metaboliche dell'Osso, Università degli Studi di Torino, Torino, Italy National Ageing Research Institute, Parkville, Victoria, Australia
Ping Zhang
Affiliation:
Commonwealth Scientific and Industrial Research Organisation (CSIRO), Parkville, Victoria, Australia
David Ames*
Affiliation:
National Ageing Research Institute, Parkville, Victoria, Australia Academic Unit for Psychiatry of Old Age, University of Melbourne Department of Psychiatry, St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia
Ashley I. Bush
Affiliation:
Mental Health Research Institute, Parkville, Victoria, Australia
Nicola T. Lautenschlager
Affiliation:
Academic Unit for Psychiatry of Old Age, University of Melbourne Department of Psychiatry, St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia Centre of Excellence for Alzheimer's Disease Research & Care, School of Psychiatry and Clinical Neurosciences and WA Centre for Health and Ageing, University of Western Australia, Perth, Western Australia, Australia
Ralph N. Martins
Affiliation:
School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, WA, Australia
Colin L. Masters
Affiliation:
Mental Health Research Institute, Parkville, Victoria, Australia University of Melbourne, Parkville, Vic, Australia
Christopher C. Rowe
Affiliation:
Austin PET Centre, and University of Melbourne Department of Medicine, Austin Health, Heidelberg, Victoria, Australia
Cassandra Szoeke
Affiliation:
Commonwealth Scientific and Industrial Research Organisation (CSIRO), Parkville, Victoria, Australia National Ageing Research Institute, Parkville, Victoria, Australia
Kevin Taddei
Affiliation:
School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, WA, Australia
Kathryn A. Ellis
Affiliation:
Academic Unit for Psychiatry of Old Age, University of Melbourne Department of Psychiatry, St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia Mental Health Research Institute, Parkville, Victoria, Australia
*
Correspondence should be addressed to: Professor David Ames, Director, National Ageing Research Institute, P.O. Box 2127, Royal Melbourne Hospital, Victoria 3050, Australia. Phone: +61 3 83872305; Fax: +61 3 93874030. Email: [email protected].
Get access

Abstract

Background: The AIBL study, which commenced in November 2006, is a two-center prospective study of a cohort of 1112 volunteers aged 60+. The cohort includes 211 patients meeting NINCDS-ADRDA criteria for Alzheimer's disease (AD) (180 probable and 31 possible). We aimed to identify factors associated with rapid cognitive decline over 18 months in this cohort of AD patients.

Methods: We defined rapid cognitive decline as a drop of 6 points or more on the Mini-Mental State Examination (MMSE) between baseline and 18-month follow-up. Analyses were also conducted with a threshold of 4, 5, 7 and 8 points, as well as with and without subjects who had died or were too severely affected to be interviewed at 18 months and after, both including and excluding subjects whose AD diagnosis was “possible” AD. We sought correlations between rapid cognitive decline and demographic, clinical and biological variables.

Results: Of the 211 AD patients recruited at baseline, we had available data for 156 (73.9%) patients at 18 months. Fifty-one patients were considered rapid cognitive decliners (32.7%). A higher Clinical Dementia Rating scale (CDR) and higher CDR “sum of boxes” score at baseline were the major predictors of rapid cognitive decline in this population. Furthermore, using logistic regression model analysis, patients treated with a cholinesterase inhibitor (CheI) had a higher risk of being rapid cognitive decliners, as did males and those of younger age.

Conclusions: Almost one third of patients satisfying established research criteria for AD experienced rapid cognitive decline. Worse baseline functional and cognitive status and treatment with a CheI were the major factors associated with rapid cognitive decline over 18 months in this population.

Keywords

dementiacognitive testingmemorycognitive disorderscholinesterase inhibitor
Type
Research Article
Information
International Psychogeriatrics , Volume 24 , Issue 2 , February 2012 , pp. 197 - 204
Copyright
Copyright © International Psychogeriatric Association 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Access Economics (2009). Keeping Dementia Front of Mind: Incidence and Prevalence 2009–2050. Canberra: Alzheimer's Australia.Google Scholar
Atchison, T. B., Bradshaw, M. and Massman, P. J. (2007). Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data. Archives of Clinical Neuropsychology, 19, 1007–1015.CrossRefGoogle Scholar
Birks, J. (2006). Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews, 1, CD005593.Google Scholar
Bhargava, D., Weiner, M. F., Hynan, L. S., Diaz-Arrastia, R. and Lipton, A. M. (2006). Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 19, 78–82.CrossRefGoogle ScholarPubMed
Brodaty, H., Woodward, M., Boundy, K., Ames, D. and Balshaw, R. (2011). Patients in Australian memory clinics: baseline characteristics and predictors of decline at 6 months. International Psychogeriatrics. Epublished ahead of print, doi:10.107/S1041610211000688.Google Scholar
Burns, A., Jacoby, R. and Levy, R. (1991). Progression of cognitive impairment in Alzheimer's disease. Journal of the American Geriatrics Society, 39, 39–45.CrossRefGoogle ScholarPubMed
Capitani, E., Cazzaniga, R., Francescani, A. and Spinnler, H. (2004). Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages? Neurological Sciences, 25, 198–204.CrossRefGoogle ScholarPubMed
Carcallion, L., Peres, K, Pere, J. J., Helmer, C., Orgogozo, J. M., Dartigues, J. F. (2007). Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community. Dementia and Geriatric Cognitive Disorders, 24, 138–145.Google Scholar
Clark, C. M. et al. (1999). Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease. Archives of Neurology, 56, 857–862.CrossRefGoogle ScholarPubMed
Doody, R. S., Massman, P. and Dunn, K. (2001). A method for estimating progression rates in Alzheimer's disease. Archives of Neurology, 58, 449–454.CrossRefGoogle Scholar
Doody, R. S., Pavlik, V., Massman, P., Rountree, S., Darby, E. and Chan, W. (2010). Predicting progression of Alzheimer's disease. Alzheimer's Research and Therapy, 2, 2–9.CrossRefGoogle ScholarPubMed
Ellis, K. A., et al. (2009). The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672–687.CrossRefGoogle ScholarPubMed
Flicker, L. (2010). Screening and assessment instruments for the detection and measurement of cognitive impairment. In Ames, D., Burns, A., , A. and O'Brien, J. (eds.), Dementia 4th edn. (p. 57). London: Hodder Arnold.Google ScholarPubMed
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle ScholarPubMed
Gillette-Guyonnette, S., et al. (2006). Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 61, 516–520.CrossRefGoogle Scholar
Holtzer, R. et al. (2003). The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer's disease. Archives of Neurology, 60, 1137–1142.CrossRefGoogle Scholar
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939–944.CrossRefGoogle ScholarPubMed
Mendiondo, M. S., Ashford, J. W., Kryscio, R. J. and Schmitt, F. A. (2000) Modeling Mini Mental State Examination changes in Alzheimer's disease. Statistical Medicine, 19, 1607–1616.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.CrossRefGoogle ScholarPubMed
Morris, J. C., et al. (1993). The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology, 43, 2457–2465.CrossRefGoogle Scholar
Musicco, M. et al. (2010). Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 30, 219–228CrossRefGoogle ScholarPubMed
O'Hara, R. et al. (2002). Which Alzheimer patients are at risk for rapid cognitive decline? Journal of Geriatric Psychiatry and Neurology, 15, 233–238.CrossRefGoogle ScholarPubMed
Ousset, P. J., Nourhashemi, F., Reynish, E. and Vellas, B. (2008). Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Disease and Associated Disorders, 22, 66–71.CrossRefGoogle ScholarPubMed
Petersen, R. C. et al. (2009). Mild cognitive impairment: ten years later. Archives of Neurology, 66, 1447–1455.CrossRefGoogle ScholarPubMed
R Development Core Team (2010). R: a Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing. See http://www.R-project.org.Google Scholar
Rowe, C. et al. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging, 31, 1275–1283.CrossRefGoogle ScholarPubMed
Schneider, L. S., Insel, P. S. and Weiner, M. W.for the Alzheimer's Disease Neuroimaging Initiative. (2011). Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of Neurology, 68, 58–66.CrossRefGoogle ScholarPubMed
Sona, A., Ellis, K. and Ames, D. (submitted). Rapid cognitive decline in Alzheimer's disease: a selective review of the literature. Submitted to International Psychogeriatrics.Google Scholar
Soto, M. E., Gillette-Guyonnet, S., Vellas, B.and the REAL.FR group. (2005). Rapid cognitive decline: searching for a definition and predictive factor among elderly with Alzheimer's disease. Journal of Nutrition, Health and Aging, 9, 158–161.Google ScholarPubMed
Soto, M. E. et al. (2008a). Rapid cognitive decline in Alzheimer disease. Consensus paper Journal of Nutrition Health and Aging, 12, 703–713.CrossRefGoogle ScholarPubMed
Soto, M. E. et al. (2008b). Predictive value of rapid decline in Mini Mental State Examination in clinical practice for prognosis in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 26, 109–116.CrossRefGoogle ScholarPubMed
Winblad, B. et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240–246.CrossRefGoogle Scholar